shilepu (donepezil hydrochloride tablets)-比较正规的买球软件

中

比较正规的买球软件-买球软件推荐-买球app软件 english

about us
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
news
- company news
- media focus
- with the objective of 'creating excellence in china's pharmaceuticals and add momentum to "made in china"',hansoh endeavors to make its own contribution to the “healthy china 2030” master plan.
- with the objective of 'creating excellence in china's pharmaceuticals and add momentum to "made in china"',hansoh endeavors to make its own contribution to the “healthy china 2030” master plan.
products
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
r&d
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
services
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate
contact us
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.

shilepu (donepezil hydrochloride tablets)

donepezil hydrochloride tablets

english name: donepezil hydrochloride tablets

chinese pinyin: yansuan duonaipaiqi pian

the main ingredient is donepezil hydrochloride.

chemical name: 5,6-dimethoxy-2-[(1-phenylmethyl-4-piperidinyl)-methyl]-2,3-dihydro-1h-indolone hydrochloride.

/en/upload/images/2017/06/06/e0f74254d366484f8db25a768048850d.png

【name】	common name: donepezil hydrochloride tablets english name: donepezil hydrochloride tablets chinese pinyin: yansuan duonaipaiqi pian
【ingredient】	the main ingredient is donepezil hydrochloride. chemical name: 5,6-dimethoxy-2-[(1-phenylmethyl-4-piperidinyl)-methyl]-2,3-dihydro-1h-indolone hydrochloride. chemical structure: molecular formula: c₂₄h₂₉no₃·hcl molecular weight: 415.96
【description】	this product is a film-coated tablet. it is white or off-white after removal of the film coating.
【indication】	it is indicated for the treatment of mild and moderate dementia of alzheimer’s type.
【strength】	5mg。
【dosage and administration】	adult/elderly: the recommended starting dosage is 5 mg (1 tablet) administered once per day in the evening, just prior to retiring. the daily dose of 5 mg should be maintained for at least one month to evaluate the early clinical efficacy, as well as to achieve a steady-state plasma concentration of donepezil hydrochloride. after a clinical evaluation of treatment with daily dose of 5 mg for one month, the daily dose of this product can be increased to 10 mg (2 tablets). the recommended maximum daily dose is 10 mg. a dose greater than 10 mg/day has not been clinically evaluated. after stopping treatment, the efficacy gradually diminished. discontinuation of treatment has no rebound phenomenon.